| Capitol City Rehab And Healthcare Center | |
| 2425 25th Street Se, Washington, District Of Columbia 20020 | |
| (202) 889-3600 | |
| Name | Capitol City Rehab And Healthcare Center |
|---|---|
| Location | 2425 25th Street Se, Washington, District Of Columbia |
| Certified By | Medicare and Medicaid |
| No. of Certified Beds | 360 |
| Occupancy Rate | 82.19% |
| Medicare ID (CCN) | 095022 |
| Legal Business Name | Capitol City Snf Llc |
| Ownership Type | For Profit - Limited Liability Company |
| NPI Number | 1285059550 |
| Organization Name | WASHINGTON NURSING & REHABILITATION LLC |
| Doing Business As | WASHINGTON NURSING FACILITY |
| Address | 2425 25th St Se, Washington, DC 20020 |
| Phone Number | 202-889-3600 |
News Archive
BELLUS Health Inc. ("BELLUS Health" or the "Company") (TSX: BLU) today disclosed the results of its previously announced rights offering. The Company will raise an aggregate of C$9,687,233 from the rights offering and issue a total of 52,363,419 common shares at a price of C$0.185 per share (the "Subscription Price").
W. L. Gore & Associates announced the treatment of the first European patients with the new 25 cm GORE® VIABAHN® Endoprosthesis with PROPATEN Bioactive Surface, the longest length stent-graft available in Europe. Piotr Kasprzak, from the Department of Vascular Surgery at the Klinikum der Universität in Regensburg, Germany, and Thomas Zeller, MD, from the Department of Angiology at the Herz-Zentrum in Bad Krozingen, Germany successfully treated patients using the Gore device.
In a special series, IRIN examines health and development in Kenya. "The vast arid lands of northern Kenya are generally drier, less fertile, poorer and rank lower in most humanitarian and development league tables than the rest of the country. ... Preventable and treatable diseases are often neither prevented nor treated for want of adequate healthcare. Attracting qualified doctors and nurses to the hinterland is a major challenge.
A new treatment for prostate cancer called Provenge won a vote of confidence from a Medicare coverage advisory committee Wednesday, suggesting the federal program is likely to pay for the $93,000-per-patient medicine.
GPs struggling to balance their books in the face of rising expenses and a zero percent increase in funding will have to take tough, business-minded decisions to minimise the effect on both their practices and patient services, advises the BMA's General Practitioners Committee (GPC).
› Verified 2 days ago
| NPI Number | 1760028427 |
| Organization Name | CAPITOL CITY SNF LLC |
| Doing Business As | CAPITOL CITY REHAB AND HEALTHCARE CENTER |
| Address | 2425 25th St Se, Washington, DC 20020 |
| Phone Number | 202-889-3600 |
News Archive
BELLUS Health Inc. ("BELLUS Health" or the "Company") (TSX: BLU) today disclosed the results of its previously announced rights offering. The Company will raise an aggregate of C$9,687,233 from the rights offering and issue a total of 52,363,419 common shares at a price of C$0.185 per share (the "Subscription Price").
W. L. Gore & Associates announced the treatment of the first European patients with the new 25 cm GORE® VIABAHN® Endoprosthesis with PROPATEN Bioactive Surface, the longest length stent-graft available in Europe. Piotr Kasprzak, from the Department of Vascular Surgery at the Klinikum der Universität in Regensburg, Germany, and Thomas Zeller, MD, from the Department of Angiology at the Herz-Zentrum in Bad Krozingen, Germany successfully treated patients using the Gore device.
In a special series, IRIN examines health and development in Kenya. "The vast arid lands of northern Kenya are generally drier, less fertile, poorer and rank lower in most humanitarian and development league tables than the rest of the country. ... Preventable and treatable diseases are often neither prevented nor treated for want of adequate healthcare. Attracting qualified doctors and nurses to the hinterland is a major challenge.
A new treatment for prostate cancer called Provenge won a vote of confidence from a Medicare coverage advisory committee Wednesday, suggesting the federal program is likely to pay for the $93,000-per-patient medicine.
GPs struggling to balance their books in the face of rising expenses and a zero percent increase in funding will have to take tough, business-minded decisions to minimise the effect on both their practices and patient services, advises the BMA's General Practitioners Committee (GPC).
› Verified 2 days ago
| NPI Number | 1811305451 |
| Organization Name | TRANSITIONS HEALTHCARE CAPITOL CITY, LLC |
| Address | 2425 25th St Se, Washington, DC 20020 |
| Phone Number | 202-889-3600 |
News Archive
BELLUS Health Inc. ("BELLUS Health" or the "Company") (TSX: BLU) today disclosed the results of its previously announced rights offering. The Company will raise an aggregate of C$9,687,233 from the rights offering and issue a total of 52,363,419 common shares at a price of C$0.185 per share (the "Subscription Price").
W. L. Gore & Associates announced the treatment of the first European patients with the new 25 cm GORE® VIABAHN® Endoprosthesis with PROPATEN Bioactive Surface, the longest length stent-graft available in Europe. Piotr Kasprzak, from the Department of Vascular Surgery at the Klinikum der Universität in Regensburg, Germany, and Thomas Zeller, MD, from the Department of Angiology at the Herz-Zentrum in Bad Krozingen, Germany successfully treated patients using the Gore device.
In a special series, IRIN examines health and development in Kenya. "The vast arid lands of northern Kenya are generally drier, less fertile, poorer and rank lower in most humanitarian and development league tables than the rest of the country. ... Preventable and treatable diseases are often neither prevented nor treated for want of adequate healthcare. Attracting qualified doctors and nurses to the hinterland is a major challenge.
A new treatment for prostate cancer called Provenge won a vote of confidence from a Medicare coverage advisory committee Wednesday, suggesting the federal program is likely to pay for the $93,000-per-patient medicine.
GPs struggling to balance their books in the face of rising expenses and a zero percent increase in funding will have to take tough, business-minded decisions to minimise the effect on both their practices and patient services, advises the BMA's General Practitioners Committee (GPC).
› Verified 2 days ago
| Ratings from Surveys (Inspections): | |
| Ratings from Quality Measures: | |
| Ratings from Staffing Data: | |
| Overall Rating: |
|---|
News Archive
BELLUS Health Inc. ("BELLUS Health" or the "Company") (TSX: BLU) today disclosed the results of its previously announced rights offering. The Company will raise an aggregate of C$9,687,233 from the rights offering and issue a total of 52,363,419 common shares at a price of C$0.185 per share (the "Subscription Price").
W. L. Gore & Associates announced the treatment of the first European patients with the new 25 cm GORE® VIABAHN® Endoprosthesis with PROPATEN Bioactive Surface, the longest length stent-graft available in Europe. Piotr Kasprzak, from the Department of Vascular Surgery at the Klinikum der Universität in Regensburg, Germany, and Thomas Zeller, MD, from the Department of Angiology at the Herz-Zentrum in Bad Krozingen, Germany successfully treated patients using the Gore device.
In a special series, IRIN examines health and development in Kenya. "The vast arid lands of northern Kenya are generally drier, less fertile, poorer and rank lower in most humanitarian and development league tables than the rest of the country. ... Preventable and treatable diseases are often neither prevented nor treated for want of adequate healthcare. Attracting qualified doctors and nurses to the hinterland is a major challenge.
A new treatment for prostate cancer called Provenge won a vote of confidence from a Medicare coverage advisory committee Wednesday, suggesting the federal program is likely to pay for the $93,000-per-patient medicine.
GPs struggling to balance their books in the face of rising expenses and a zero percent increase in funding will have to take tough, business-minded decisions to minimise the effect on both their practices and patient services, advises the BMA's General Practitioners Committee (GPC).
› Verified 2 days ago
| Number of Facility Reported Incidents | 0 |
| Number of Substantiated Complaints | 0 |
| Number of Fines | 1 |
| Total Amount of Fines in Dollars | $9750 |
| Number of Payment Denials | 0 |
| Total Number of Penalties | 1 |
| Experience Measure | Provider | National Avg. |
|---|---|---|
| Percentage of long-stay residents whose need for help with daily activities has increased | 14.67 | 14.46 |
| Percentage of long-stay residents who lose too much weight | 5.87 | 5.51 |
| Percentage of low risk long-stay residents who lose control of their bowels or bladder | 42.81 | 48.41 |
| Percentage of long-stay residents with a catheter inserted and left in their bladder | 1.05 | 1.79 |
| Percentage of long-stay residents with a urinary tract infection | 0.56 | 2.65 |
| Percentage of long-stay residents who have depressive symptoms | 1.16 | 5.05 |
| Percentage of long-stay residents who were physically restrained | 1.56 | 0.23 |
| Percentage of long-stay residents experiencing one or more falls with major injury | 0.35 | 3.36 |
| Percentage of long-stay residents assessed and appropriately given the pneumococcal vaccine | 97.15 | 93.87 |
| Percentage of long-stay residents who received an antipsychotic medication | 20 | 14.2 |
| Percentage of short-stay residents assessed and appropriately given the pneumococcal vaccine | 95.31 | 83.88 |
| Percentage of short-stay residents who newly received an antipsychotic medication | 2.64 | 1.79 |
| Percentage of long-stay residents whose ability to move independently worsened | 21.31 | 17.09 |
| Percentage of long-stay residents who received an antianxiety or hypnotic medication | 9.98 | 19.7 |
| Percentage of high risk long-stay residents with pressure ulcers | 18.42 | 7.32 |
| Percentage of long-stay residents assessed and appropriately given the seasonal influenza vaccine | 95.76 | 95.98 |
| Percentage of short-stay residents who made improvements in function | 65.25 | 67.99 |
| Percentage of short-stay residents who were assessed and appropriately given the seasonal influenza vaccine | 90.72 | 82.93 |
News Archive
BELLUS Health Inc. ("BELLUS Health" or the "Company") (TSX: BLU) today disclosed the results of its previously announced rights offering. The Company will raise an aggregate of C$9,687,233 from the rights offering and issue a total of 52,363,419 common shares at a price of C$0.185 per share (the "Subscription Price").
W. L. Gore & Associates announced the treatment of the first European patients with the new 25 cm GORE® VIABAHN® Endoprosthesis with PROPATEN Bioactive Surface, the longest length stent-graft available in Europe. Piotr Kasprzak, from the Department of Vascular Surgery at the Klinikum der Universität in Regensburg, Germany, and Thomas Zeller, MD, from the Department of Angiology at the Herz-Zentrum in Bad Krozingen, Germany successfully treated patients using the Gore device.
In a special series, IRIN examines health and development in Kenya. "The vast arid lands of northern Kenya are generally drier, less fertile, poorer and rank lower in most humanitarian and development league tables than the rest of the country. ... Preventable and treatable diseases are often neither prevented nor treated for want of adequate healthcare. Attracting qualified doctors and nurses to the hinterland is a major challenge.
A new treatment for prostate cancer called Provenge won a vote of confidence from a Medicare coverage advisory committee Wednesday, suggesting the federal program is likely to pay for the $93,000-per-patient medicine.
GPs struggling to balance their books in the face of rising expenses and a zero percent increase in funding will have to take tough, business-minded decisions to minimise the effect on both their practices and patient services, advises the BMA's General Practitioners Committee (GPC).
› Verified 2 days ago
Washington Ctr For Aging Svcs Location: 2601 18th Street Ne, Washington, District Of Columbia 20018 Phone: (202) 541-6140 | |
Serenity Rehabilitation And Health Center Llc Location: 1380 Southern Ave Se, Washington, District Of Columbia 20032 Phone: (202) 279-5880 | |
Deanwood Rehabilitation And Wellness Center Location: 5000 Burroughs Ave. Ne, Washington, District Of Columbia 20019 Phone: (202) 399-7504 | |
Stoddard Baptist Nursing Home Location: 1818 Newton St. Nw, Washington, District Of Columbia 20010 Phone: (202) 328-7400 | |
Capitol City Rehab And Healthcare Center Location: 2425 25th Street Se, Washington, District Of Columbia 20020 Phone: (202) 889-3600 | |
Bridgepoint Subacute And Rehab National Harbor Location: 4601 Martin Luther King Jr Avenue Sw, Washington, District Of Columbia 20032 Phone: (202) 279-3005 |